drugset / Trial / NCT01029522
Dyslipidemia in Cardiovascular Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
A multi-center, randomized, double-blinded equivalence clinical trial to evaluate efficacy and safety of LipiLou 20 mg versus Lipitor 20 mg in hypercholesterolemic patients with higher risk cardiovascular disease in Korea.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-10
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | Oral |